NCT06094777 2024-06-13
A Study of HY-0102 in Patients With Advanced Solid Tumors
Shanghai YingLi Pharmaceutical Co. Ltd.
Phase 1 Unknown
Shanghai YingLi Pharmaceutical Co. Ltd.
Shanghai Junshi Bioscience Co., Ltd.
Merrimack Pharmaceuticals
Cell Genesys